Insulin resistance parameters in children born very preterm and adequate for gestational age
- PMID: 35194980
- PMCID: PMC9094455
- DOI: 10.1002/edm2.329
Insulin resistance parameters in children born very preterm and adequate for gestational age
Abstract
Background: Preterm neonates are at risk for metabolic syndrome later in life. Whether prematurity constitutes an independent risk factor for the development of cardiovascular disease and metabolic syndrome remains controversial.
Objective: To compare anthropometric measures, cardiometabolic risk factors and insulin resistance variables between children who were born very preterm (VPT, <32 gestational weeks) and at term (Term, >37 gestational weeks) and adequate for gestational age (AGA).
Methods: We designed a cross-sectional cohort study, recruiting 120 children (5.0-8.5 years old) from the preterm clinic at Red de Salud UC-Christus and Complejo Asistencial Dr. Sótero del Río, and term children from the community. We excluded children born small for gestational age, based on INTERGROWTH21. Anthropometrics data were classified using WHO reference standards. The homeostasis model assessment insulin resistance (HOMA-IR) index, quantitative insulin sensitivity check index (QUICKI), triglyceride-to-HDL-C ratio (TG/HDL-C) and Pediatric Score Index for Metabolic Syndrome (PsiMS) were calculated.
Results: VPT children born AGA had lower HDL cholesterol levels (p = .019) and a higher PsiMS score than those born at term (p = .043). We observed a higher percentage of children with HDL cholesterol ≤40 mg/dl (13.0% vs. 2.3%, p = .026) and BP ≥90th percentile among the VPT children than among the Term children (26.0% vs. 11.6%, p = .031).
Conclusions: At school age, blood pressure was higher, and HDL-C was lower among VPT children born AGA, suggesting a potential metabolic risk; therefore, it is essential to follow this group throughout their lives.
Keywords: HOMA; PsiMS; insulin resistance; metabolic syndrome; premature.
© 2022 The Authors. Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors have no financial or nonfinancial conflicts of interest to declare in association with this work. The authors declare no conflicts of interest.
References
-
- Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415‐1428. - PubMed
-
- O'Neill S, O'Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16:1‐12. - PubMed
-
- Balasuriya CND, Stunes AK, Mosti MP, et al. Metabolic outcomes in adults born preterm with very low birth weight or small for gestational age at term: a cohort study. J Clin Endocrinol Metab. 2018;103:4437‐4446. - PubMed
-
- Heron M. Deaths: leading causes for 2017. Natl Vital Stat Rep. 2019;68:1‐77. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous